DOCSLIB.ORG

Standard Eposter

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Standard Eposter SIU 2020 Abstract Listing Last Updated: October 09, 2020 Standard ePoster Adrenals SP-01.01 A 16 Year Review of Management of Incidental Adrenal Masses: Should We Remove Based on Size Alone? Melissa Gabriel, United Kingdom SP-01.02 Laparoscopic Adrenalectomy for Malignant Tumors: A Retrospective Analysis of Kyushu University Hospital Keisuke Monji, Japan SP-01.03 Laparoscopic Adrenalectomy: Outcomes of Enhanced Recovery Pathways at our Regional Cancer Centre Flora Langman, United Kingdom Basic Science - Benign Diseases SP-02.01 Comparative Analysis of Gut Microbiome Composition Between Men with Peyronie’s Disease and a Matched Cohort: Is there a Difference? Mohamad Osman, United States SP-02.02 Congenital Malformations of the Genito-Urinary Tract Associated to Isodicentric Yq Chromosome Nouha Bouayed Abdelmoula, Tunisia SP-02.03 Establishment of Infectious Stone in Rats Yang Hong, China SP-02.04 Knockout of Phosphatidylethanolamine Binding Protein 4 (PEBP4) Induces Prostatovesiculitis via NF-κB Signaling Xiaofeng Zou, China All SIU 2020 abstracts may be viewed via SIU Academy. 1/56 SIU 2020 Abstract Listing Last Updated: October 09, 2020 SP-02.05 Nerve Growth Factor Precursor (proNGF) Exerts Different Biological Actions on Urothelial and Smooth Muscle Cells of Rodents Bladders Abubakr Mossa, Canada SP-02.06 Renal Denervation Alleviate Renal Ischemic Reperfusion Injury Induced Acute and Chronic Kidney Injury Partly by Modulating miRNAs in Rats Jie Sun, China Bladder Cancer SP-03.01 ADNP Prompts the Progression of Bladder Cancer via Transforming Growth Factor (TGF)-β-Mediated Epithelial-Mesenchymal Transition (EMT) Pathway Yu Xie, China SP-03.02 Effect of Low Energy Shock Wave Therapy on Intravesical Epirubicin Delivery in a Rat Model of Bladder Cancer Ahmed Elkashef, Egypt SP-03.03 Global BCG Shortage Affects Bladder Cancer Treatment Michael Harvey, Australia SP-03.04 Investigating the Association between the Urinary Microbiome and Bladder Cancer: An Exploratory Study Umar Iqbal, United States SP-03.05 Molecular Visualization of Orthotopic Bladder Tumors in Dogs Under Confocal Laser Endomicroscopy Zhenduo Shi, China SP-03.06 Multimodal Fiber Optic Spectroscopy for Detecting Tumor Grade and Stage in Urothelial Cancer Diagnosis. Current Results Simone Morselli, Italy SP-03.07 Observation of Curative Effect of Transurethral Thulium Laser Stratified Resection for Non-Muscle Invasive Bladder Tumor Xiaofeng Zou, China All SIU 2020 abstracts may be viewed via SIU Academy. 2/56 SIU 2020 Abstract Listing Last Updated: October 09, 2020 SP-03.08 Optimizing Sequence of Therapy and Radiation Delivery When Combined with PD-L1 Immune- Checkpoint Inhibition in Bladder Cancer Côme Tholomier, Canada SP-03.09 Preparation of Bitter Gourd Ribosomal Inactivating Protein MAP30 and the Study of Inhibition on Bladder Urothelial Carcinoma Zhenduo Shi, China SP-03.10 Review of Bacillus Calmette-Guerin (BCG) Tolerability and Complications of Intravesical Therapy for Non- Muscle Invasive Bladder Cancer (NMIBC) Over a 4 Year Period Venetia Hoe, Australia SP-03.11 The FOXA1-KDM6A-ARHGDIB Axis Suppresses Cell Migration and Invasion in Human Bladder Cancer Lei Liu, China SP-03.12 The Promising Diagnostic Accuracy of Methylation Genes in Urine for the Detection of Bladder Cancer Yu Xie, China SP-03.13 The Role of Perpheric Inflammatory Markers in the Prognosis of Non-Muscle Invasive Bladder Cancer Roberto Martínez, Spain SP-03.14 “Two-Zone and Three-Segment” Laparoscopic Radical Cystectomy vs Conventional Laparoscopic Radical Cystectomy for Male Patients with Bladder Urothelial Carcinoma: A Retrospective Analysis Benkang Shi, China SP-03.15 Anaerobic Threshold Correlated to Length of Hospital Stay and Complication Rate for Radical Cystectomy Patients Mriganka Mani Sinha, United Kingdom SP-03.16 Assessing the Safety of Follow-Up After Induction BCG Using Urine Cytology and Flexible Cystoscopy Lisa Bibby, United Kingdom SP-03.17 Comparing Costs of Radical Versus Partial Cystectomy for Patients Diagnosed with Localized Muscle- Invasive Bladder Cancer: Understanding the Value of Surgical Care Aditya Srinivasan, United States All SIU 2020 abstracts may be viewed via SIU Academy. 3/56 SIU 2020 Abstract Listing Last Updated: October 09, 2020 SP-03.18 Comparison Between Primary and Secondary Muscle-Invasive Bladder Cancer Based on a Chinese Cohort from West China Hospital Xiaonan Zheng, China SP-03.19 Comparison Low Pressure to Standard Pressure Robotic Assisted Radical Cystectomy: A Pilot study Vishwanath Hanchanale, United Kingdom SP-03.20 Comparison of Open Radical Cystectomy versus Robotic assisted Radical Cystectomy: Our experience at Tertiary Care Centre Avinash Ranganagouda Odugoudar, United Kingdom SP-03.21 Complete Urinary Tract Exenteration (CUTE) for Invasive Bladder Urothelial Carcinoma in ESRD Patient on Hemodialysis Magdy El-Bahnasawy, Saudi Arabia SP-03.22 Could Urinary-Based Molecular Markers Discriminate between Non-Muscle Invasive and Muscle Invasive Bladder Cancer? Ahmed Elkashef, Egypt SP-03.23 COVID-19 and Bladder Cancer: Are Social and Clinical Restrictions Presenting Barriers to Patients Requiring Transurethral Resection of Bladder Tumour (TURBT)? Dominic Bagguley, Australia SP-03.24 Diagnostic and Surveillance Cystoscopy for Bladder Cancer – Pushing Boundaries During COVID-19 Dominic Bagguley, Australia SP-03.25 Do Urinary-Based Molecular Biomarkers Have the Ability to Predict the Grade of Non-Muscle Invasive Bladder Cancer? Ahmed Elkashef, Egypt SP-03.26 Enhanced Recovery After Surgery for Robotic-Assisted Laparoscopic Radical Cystectomy: A Single-Center Experience Fu Ho Victor Cheung, Hong Kong SP-03.27 Geographic Distribution of Racial Differences in Bladder Cancer Mortality in the United States: A Nationwide Population-Based Study Ariza Martinez, United States All SIU 2020 abstracts may be viewed via SIU Academy. 4/56 SIU 2020 Abstract Listing Last Updated: October 09, 2020 SP-03.28 Immunotherapy in Advanced Urothelial Cancer: Initial Experience Lorena García García, Spain SP-03.29 Is Re-Resection TUR Always Needed in the Management of Patients with High-Risk Non-Muscle-Invasive Bladder Cancer (TaG3/T1 with or without CIS) Treated with Bacillus Calmette-Guerin? Kenneth Hiew, United Kingdom SP-03.30 Is There a Difference Between Intravesical Chemotherapy and Immunotherapy for the Non-Muscle Invasive Bladder Cancer in Real Practice?: A Prospective Multicenter Study Phil Hyun Song, South Korea SP-03.31 Multiparametric 3T MRI for Staging of Bladder Cancer: Radiologic and Histopathologic Comparison from a Single Australian Center Ting Yiu, Australia SP-03.32 Oncological Outcomes of Contemporary Series of Robot-Assisted versus Open Radical Cystectomy at 10 Years Follow up Muhammad Waqar, United Kingdom SP-03.33 Oncological, Sexual, and Urinary Outcomes of Organ-Sparing Cystectomy versus Standard Radical Cystectomy: A Systematic Review and Meta-Analysis Raghav Shaunak, United Kingdom SP-03.34 Osmotic Cytolytic Effects of Water on Cell Counts - Implication for Clinical Use of Water Irrigation to Reduce NMIBC Recurrence Ruchira Nandurkar, Australia SP-03.35 Outpatient Transurethral Laser Ablation for Urothelial Cancer – A Safe Alternative to TURBT in the Era of COVID-19 James Aljoe, United Kingdom SP-03.36 Perioperative and Oncologic Outcomes of Robot-Assisted Radical Cystectomy in North American versus European Institutes Utilizing the International Robotic Cystectomy Consortium Umar Iqbal, United States SP-03.37 All SIU 2020 abstracts may be viewed via SIU Academy. 5/56 SIU 2020 Abstract Listing Last Updated: October 09, 2020 Preliminary Study of the Safety of Ethacridine Lactate for Visualizing of Cancer Nuclei Using Probe-Based Confocal Laser Endomicroscopy During Transurethral Resection of Bladder Cancer Yoshio Naya, Japan SP-03.38 Prognostic Significance of Pre-Operative Neutrophil Lymphocyte Ratio (NLR) in Patients with Muscle Invasive Bladder Cancer: A Retrospective Analysis Ritesh Goel, India SP-03.39 Prostate Specific Membrane Antigen (PSMA) in Urothelial Cell Carcinoma (UCC): A Systematic Review of the Literature Arsalan Tariq, Australia SP-03.40 Proximity to Oil Refineries and Risk of Bladder Cancer: A Population-Based Analysis Aditya Srinivasan, United States SP-03.41 Radical Cystectomies – Too Many Doing Too Few Reflects in Length of Stay Nuno Dias, Portugal SP-03.42 Radical Cystectomy in Elderly Patients: Postoperative Complications and Oncological Outcomes Alberto del Cristo Artiles Medina, Spain SP-03.43 Relapse Rates, Patterns, and Survival After Robot-Assisted Radical: Results from the International Robotic Cystectomy Consortium Umar Iqbal, United States SP-03.44 Robotic Cystectomy Histopathology Outcomes in Patients Who Have ‘Failed’ BCG Edward Hart, United Kingdom SP-03.45 Role of the Preoperative Magnetic Resonance Imaging in Classifying Non-Muscle and Muscle Invasive Bladder Cancer Teak Jun Shin, South Korea SP-03.47 The Peri-Meatus Location of Non-Muscle Invasive Bladder Cancer (T1): Is It a Risk Factor of Recurrence and Progression? About 274 Cases Sataa Sallami, Tunisia All SIU 2020 abstracts may be viewed via SIU Academy. 6/56 SIU 2020 Abstract Listing Last Updated: October 09, 2020 SP-03.48 Trends of Neobladder Formation in Australia Elena Galiabovitch, Australia SP-03.49 Urine Cytology: Why Don't Requesting Clinicians Follow Guidelines? Jake Tempo, Australia SP-03.50 Value of Using T2-Weighted 3-Tesla Magnetic Resonance Imaging in the Diagnosis of Localized Bladder Cancer Prior to Radical Cystectomy: Preliminary
Load more

Recommended publications
  • Urotoday International Journal Volume 5 - April 2012 Table of Contents: April, 2012
    ® UIJ UroToday International Journal www.urotodayinternationaljournal.com Volume 5 - April 2012 Table of Contents: April, 2012 Review • Urological Cancer Metastasis to the Brain: When Should We Resect? Zachary Klaassen, Faris Shweikeh, Ronald S Chamberlain Laparoscopic Live Donor Nephrectomy • Prevalence and Risk Factors Associated with Overactive Bladder George P Abraham, Krishanu Das, Krishnamohan Ramaswami, Datson P George, Jisha J Abraham, Thomas J Tachil, Oppukeril S Thampan Percutaneous Nephrolithotripsy • Outcomes of Prone and Complete Supine Percutaneous Nephrolithotripsy According to Body Mass Index Siavash Falahatkar, Marzieh Akbarpour, Ahmad Enshaei, Samaneh Esmaeili, Amin Afsharimoghaddam Prostatic Abscess • Transrectal Sectional Sonography (TRSS) in the Diagnosis and Treatment of Prostatic Abscesses Salah Elwagdy, Mohamed A-Khalek, Abdalla El-Kheshen, Abdel Aziz Aun, Ahmed Eldaly, Amr Mostafa, Ehab Adel, Ashraf Enite Stress Urinary Incontinence • Laparoscopic or Robotic Sacrocolpopexy with Tension-Free Sling to Prevent and Treat Symptomatic or Occult Stress Urinary Incontinence Lauren B Westermann, Jessika Kissling, Neena Agarwala Transitional Cell Carcinoma of the Bladder • Transitional Cell Carcinoma of the Bladder in Young Adults: Presentation, Natural History, and Outcome of 158 Cases Sallami Satâa, Adel Dahmani, Karim Cherif, Ines Chelly, Nidhameddine Kchir, Ali Horchani Urethral Replacement • Decellularized Porcine-Derived Blood Vessel Matrix Graft for Urethral Replacement in a Rabbit Model Sam Kuykendall, Gilad A Amiel,
    [Show full text]
  • Underuse and Potential Detrimental Effect of Radiotherapy in the Management of Ureteral Cancer Reza Nabavizadeh Virginia Commonwealth University
    Virginia Commonwealth University VCU Scholars Compass MD Student Summer Research Fellowship Program School of Medicine Posters 2016 Underuse and Potential Detrimental Effect of Radiotherapy in the Management of Ureteral Cancer Reza Nabavizadeh Virginia Commonwealth University Mashya Abbassi Virginia Commonwealth University Emma C. Fields MD Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/mds_posters Part of the Medicine and Health Sciences Commons Downloaded from https://scholarscompass.vcu.edu/mds_posters/1 This Poster is brought to you for free and open access by the School of Medicine at VCU Scholars Compass. It has been accepted for inclusion in MD Student Summer Research Fellowship Program Posters by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. Underuse and Potential Detrimental Effect of Radiotherapy in the Management of Ureteral Cancer Reza Nabavizadeh, Mashya Abbassi, Wen Wan, B. Mayer Grob, Emma Fields Virginia Commonwealth University School of Medicine Overall Survival Cause-Specific Survival Hazard 95% Hazard Ratio Hazard 95% Hazard Ratio Abstract Results Ratio Confidence Limits Ratio Confidence Limits 6057 patients were identified with a mean age of Ureteral cancer is extremely rare, with only 3530 cases 70.57±10.37SD, 64.88% were male, 61.32% had renal pelvic 2.159 1.634 2.852 predicted in 2016. Therefore, published studies on ureteral Radiation: 1.433 1.233 1.665 carcinoma and 38.68% had ureteral carcinoma, 2601 (42.94%) Yes cancers are limited to single-institution retrospective had localized tumor and 3456 (57.06%) had regional disease. 1.200 1.044 1.378 studies, which have not elucidated a clear recommendation Gender: 0.877 0.823 0.935 The majority of cases were transitional cell carcinoma (96.67%), Female on the best treatment modality.
    [Show full text]
  • Diagnosis Easily Missed - Upper Urothelial Tumour
    Postgrad Med J: first published as 10.1136/pgmj.64.755.676 on 1 September 1988. Downloaded from Postgraduate Medical Journal (1988) 64, 676-677 Missed Diagnosis Diagnosis easily missed - upper urothelial tumour G.R. Mufti and J.S. Virdi Department of Urology, Whipps Cross Hospital, Leytonstone, London Eli JNT, UK. Summary: Four patients with transitional cell tumour of the renal pelvis and ureter who had atypical presentations are described. The associated presenting problem delayed an earlier diagnosis in two patients and facilitated it in the other two. Introduction Transitional cell tumours of the renal pelvis and bladder mucosa was performed. Histological exam- ureter are relatively uncommon.' Forty-six cases ination showed multiple Tl GI papillary tumours in were recorded in our department over a 16-year the pelvis and lower ureter. The patient was well 3, period (1970-86). Four of these patients had an years later. Protected by copyright. unusual clinical presentation and are reported here. Case 2 Case reports A 68 year old man presented with recurrent epi- sodes of painless haematuria. Intravenous urogram Case I showed a non-functioning right kidney. There was also a large filling defect in the bladder. Ultrasound A 65 year old man presented with repeated episodes examination of the right kidney demonstrated a of fresh bleeding per rectum. Further investigations large baggy right kidney obstructed at the pelvi- established the diagnosis of carcinoma of the rec- ureteric junction. No other lesion was seen and the tum arising from the right rectal wall. Prior to obstruction was thought to be due to primary pelvi- abdominoperineal resection, he complained of right ureteric junction obstruction.
    [Show full text]
  • Supplementary File 1
    Supplementary file 1 MOOSE Checklist The prognostic value of pretreatment plasma fibrinogen in urological cancers: a systematic review and meta-analysis Haifeng Song, Guanyu Kuang, Binglei Ma, Zhenan Zhang, Jie Jin, Qian Zhang Department of Urology, Peking University First Hospital and Institute of Urology, Peking University, National Research Center for Genitourinary Oncology, Beijing 100034, China. Corresponding Author : Qian Zhang M.D. E-mail : [email protected] Phone : +8613910970928 Jie Jin M.D. E-mail : [email protected] Phone : +8613701238632 Department of Urology, Peking University First Hospital and Institute of Urology, Peking University, Research Center for Genitourinary Oncology, 8 Xishiku Street, Xicheng District, Beijing 100034, China Criteria Brief description of how the criteria were handled in the meta-analysis Reporting of background should include Problem definition Growing evidence suggests pretreatment fibrinogen can serve as a prognostic marker in various malignancies. However, the prognostic role of plasma fibrinogen in urological cancers remains to be evaluated quantitatively because of the contradictory results from different studies. Hypothesis statement Elevated pretreatment plasma fibrinogen can predict worse survival outcomes in urological cancers. Description of study outcomes overall survival and cancer-specific survival Type of exposure or Pretreatment plasma fibrinogen intervention used Type of study designs used Cohort studies Study population No restriction. Reporting of search strategy should include Qualifications of searchers The two investigators Haifeng Song and Guanyu Kuang are trained in systematic methods of literature searching during their doctor’s studies. Search strategy, including time The detailed search strategy is shown in the supplement. 1 period included in the synthesis and keywords Databases and registries PubMed and EMBASE searched Search software used, name We did not employ a search software.
    [Show full text]
  • Upper Tract Urothelial Carcinoma: a Clinicopathologic Study Including
    Upper Tract Urothelial Carcinoma: A Clinicopathologic Study Including Microsatellite Instability Analysis Hagen Blaszyk, M.D., Linan Wang, M.D., Wolfgang Dietmaier, Ph.D., Ferdinand Hofstädter, M.D., Lawrence J. Burgart, M.D., John C. Cheville, M.D., Arndt Hartmann, M.D. Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, Minnesota (HB, LW, LJB, JCC); and Institute of Pathology, University of Regensburg, Regensburg, Germany (HB, WD, FH, AH) yposis colorectal cancer syndrome in some patients. Urothelial carcinoma of the renal pelvis and ureter These findings reinforce the importance of obtain- may develop as a manifestation of the hereditary ing cancer histories in patients with upper tract nonpolyposis colorectal cancer syndrome that is urothelial carcinoma to subsequently identify indi- characterized by mutations in a number of DNA viduals with the hereditary nonpolyposis colorectal mismatch repair genes and detectable as microsat- cancer syndrome and at-risk relatives for surveil- ellite instability. In this study, we examined micro- lance and management programs. satellite instability and the clinicopathologic fea- tures of urothelial carcinoma of the renal pelvis (n KEY WORDS: Family history, HNPCC, Microsatel- from 114 consecutive lites, Renal pelvis, Smoking, Ureter, Urothelial (53 ؍ and ureter (n (61 ؍ patients surgically treated from 1985–1992. Clinical carcinoma, data were obtained through chart review. Matched Mod Pathol 2002;15(8):790–797 normal and tumor DNA was extracted from paraffin-embedded tissue, and a panel of six micro- Urothelial carcinoma of the upper urinary tract (re- satellite loci was analyzed. The male–female ratio nal pelvis and ureter) is relatively uncommon, rep- was 2.8:1 with a median age of 70 years (range, 28 to resenting 5% of all urothelial cancers.
    [Show full text]
  • Title Acta Urologica Japonica Vol. 35, 1989 Author(S)
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Kyoto University Research Information Repository Title Acta Urologica Japonica Vol. 35, 1989 Author(s) Citation 泌尿器科紀要 (1989), 35(12): xii-xxvii Issue Date 1989-12 URL http://hdl.handle.net/2433/116762 Right Type Others Textversion publisher Kyoto University xll Acta Urologica Japonica Vol. 35, 1989 Vol. 35, No. 1January 1989 Study on Urinary (3-Glucuronidaseand Alkaline Phosphatase Activities as Indicators of CDDP Renal Toxicity ...............T. Takahashi et al.••• I Transurethral Ureterolithotripsy under Hydraulic Ureteral Dilatation .................................................................................Y. Mori et al.••• 7 Significanceof Isoantigen in the Managemantof the Urinary Bladder Tumor —A Basic Study of ABO Isoantigen in Step Sections of Entire Bladder—.................................................................................T. Ogawa et al.••• 13 An Experimental Study on Bladder Carcinogenesisin Dogs by N-Butyl-N-(4-Hydroxybutyl)Nitrosamine (BBN) and its Urinary Metabolites ............................................................S. Morishita et al.••• 27 A New Clinical Trial Intravesical Chemotherapywith Instillation of Peplomycin Preparation Emulsion in Hydroxypropylcellulosum —PreliminaryStudy of Patients with Bladder Tumor—.........M. Asakawa et al.••• 39 Studies of the New Parameter Based Urinary Flow Rate Curve in Benign Prostatic Hypertrophy ......................................................C. Haraguchi•••
    [Show full text]
  • Renal Pelvis, Ureter and Ureteral Cancer-Etiology, Epidemiology, Diagnosis and Treatment Sri Vidya A, Subrahmanyeswari PN* and Babu PS
    Review Article iMedPub Journals Skin Diseases & Skin Care 2017 http://www.imedpub.com/ Vol.2 No.1:16 Renal Pelvis, Ureter and Ureteral Cancer-Etiology, Epidemiology, Diagnosis and Treatment Sri Vidya A, Subrahmanyeswari PN* and Babu PS Department of Pharmacology, Vignan Pharmacy College, Vadlamudi, Guntur, Andhra Pradesh, India *Corresponding author: Subrahmanyeswari PN, Department of Pharmacology, Vignan Pharmacy College, Vadlamudi, Guntur, Andhra Pradesh, India, Tel: (91) 9030961817; E-mail: [email protected] Received date: Feb 27, 2017; Accepted date: Apr 03, 2017; Published date: Apr 10, 2017 Copyright: © 2017 Sri Vidya A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Citation: Sri Vidya A, Subrahmanyeswari PN, Babu PS. Renal Pelvis, Ureter and Ureteral Cancer-Etiology, Epidemiology, Diagnosis and Treatment. Skin Dis Skin Care. 2017, 2:1 the form of urine from the body (about 1-1.5 L of urine per day Abstract of which constitute 200 ml of body fluid). Structure of kidney Cancer has become more common for its progress and has less chance of treatment. The identification and Kidney is a vital bean shaped organ having a convex and prevention of cancer has been a bit difficult. Among all concave border, renal hilum is present on the concave border the types of cancers ureteral cancer is a new arising where the renal artery enters and renal vein leaves the kidney cancer which is mostly seen in women when compared to by collecting impure blood from tissue cells of kidneys.
    [Show full text]
  • The Association Between Body Mass Index and the Risk of Different Urinary Cancers: an Overview of Systematic Reviews
    The association between body mass index and the risk of different urinary cancers: an overview of systematic reviews. searching strategy of Pubmed #1 "Meta-Analysis" [Publication Type] OR "Network Meta-Analysis"[Mesh] OR "Meta-Analysis as Topic"[Mesh] #2 "Meta-Analysis"[Title/Abstract] OR "Meta Analysis"[Title/Abstract] OR "Meta-Analyses"[Title/Abstract] OR "Meta Analyses"[Title/Abstract] OR "gathering analysis"[Title/Abstract] OR "Network Meta-Analysis"[Mesh] OR "Network Meta-Analyses"[Title/Abstract] OR "Network Meta Analysis"[Title/Abstract] OR "Network Meta Analyses"[Title/Abstract] OR "Multiple Treatment Comparison Meta-Analysis"[Title/Abstract] OR "Meta Analysis"[Title/Abstract] OR "Systematic evaluation"[Title/Abstract] OR "Systematic assessment"[Title/Abstract] OR "Systematic review"[Title/Abstract] OR "Systematic reviews"[Title/Abstract] OR "System evaluation"[Title/Abstract] OR "System Assessment"[Title/Abstract] OR "Systemic review"[Title/Abstract] OR "Systemic reviews"[Title/Abstract] #3 "Urologic Neoplasms"[Mesh] OR "Urinary Bladder Neoplasms"[Mesh]) OR "Urogenital Neoplasms"[Mesh] #4 "Urological Neoplasms"[Title/Abstract] OR "Urological Neoplasm"[Title/Abstract] OR "Urinary Tract Neoplasms"[Title/Abstract] OR "Urinary Tract Neoplasm"[Title/Abstract] OR "Urologic Neoplasms"[Title/Abstract] OR "Urologic Neoplasm"[Title/Abstract] OR "Cancer of Urinary Tract"[Title/Abstract] OR "Urinary Tract Cancers"[Title/Abstract] OR "Urological Cancer"[Title/Abstract] OR "Urological Cancers"[Title/Abstract] OR "Cancer of the Urinary Tract"[Title/Abstract]
    [Show full text]
  • Chapter 40 – Renal Neoplasia
    Chapter 40 Renal Neoplasia Scott E. Delacroix Jr., Christopher G. Wood, and Eric Jonasch Renal Cell Carcinoma, 1508 Chemotherapy, 1525 Other Kidney Tumors, 1528 Epidemiology, 1508 Immunotherapy, 1525 Renal Sarcomas, 1528 Pathology and Cytogenetics, 1509 Nonmyeloablative Allogeneic Wilms’ Tumor, 1528 Molecular Biology and Hereditary Transplantation, 1526 Disorders, 1511 Renal Pelvic Tumors, 1527 Clinical and Laboratory Features, 1513 Clinical Features and Diagnostic Radiologic Diagnosis, 1514 Evaluation, 1527 Staging and Prognosis, 1516 Staging and Grading of Renal Pelvic Surgical Treatment, 1518 Tumors, 1527 Radiation Therapy, 1520 Treatment, 1527 Systemic Therapy, 1520 Renal cell carcinomas arise within the renal cortex and 2% of all cancer deaths. Worldwide, the mortality from renal account for about 80% to 85% of all primary renal neoplasms. cell carcinoma is estimated to exceed 100,000 per year.6 Transitional carcinomas arising from the renal pelvis are the The incidence varies widely from country to country, next most common, accounting for 7% to 8% of primary with the highest rates seen in Northern Europe and North renal neoplasms. Other parenchymal epithelial tumors, such America.7 Although the incidence is reported to be lower as oncocytomas, collecting duct tumors, and renal sarcomas, in individuals living in African countries,7 the incidence is are uncommon but are becoming more frequently recognized equivalent among whites and African Americans living in the pathologically. Nephroblastoma (Wilms’ tumor) is common United States.8 Historically, renal cell carcinoma was twice as in children and accounts for 5% to 6% of all primary renal common in men as in women, but more recent data suggest tumors. that this gap is beginning to narrow.
    [Show full text]
  • AUA 2019 Key Words
    AUA 2019 Key Words A Biochemical recurrence Biofeedback ACE Biologic predictors Acellular matrix Biomarkers Active surveillance Biopsy Acupuncture Bisphosphonates Adenocarcinoma Bladder Adenoma Bladder augmentation Adenovirus Bladder cancer Adrenal Bladder cells Adrenergic agonists Bladder contraction Adrenergic receptors Bladder dysfunction Adrenoceptor antagonists Bladder exstrophy Adverse events Bladder hyperactivity African Americans Bladder hypertrophy Age Bladder neck Algorithms Bladder neck obstruction Alpha-adrenergic blockade Bladder obstruction Alpha-blockers Bladder reconstruction Alpha-reductase inhibitor Bladder rupture Alpha-subtype selective compounds Bladder smooth muscle Ambiguous genitalia Bladder substitution Analgesia Bladder suspension Anatomy Bone Androgen Botulinum toxin Androgen antagonist BPH Andrology Brachytherapy Anesthesia Brain Angiogenesis Animal model C Antiangiogenesis Cadherin Antibiotics Calcium Antibody Calcium channel blocker Anticholinergics Calculi Antineoplastic agents Cancer Antioxidants Cardiovascular disease Antitumor effect Castration Apoptosis Catheterization Arteries and veins Artificial Cavernous nerve urinary sphincter Assisted Cell lines reproductive technology Cells Augmentation C-fiber Chemokines Autoimmune disease Chemotherapy Azoospermia Chromosomes Clinical protocols B Clinical trial Basic research Clusterin Behavioral modification Combination therapy Benign glands Complementary medicine Biochemical failure Complications Biochemical progression AUA 2019 Key Words Computer assisted
    [Show full text]
  • EAU Guidelines on Upper Urinary Tract Urothelial Carcinoma 2020
    EAU Guidelines on Upper Urinary Tract Urothelial Carcinoma M. Rouprêt, M. Babjuk (Chair), M. Burger (Vice-chair), E. Compérat, N.C. Cowan, P. Gontero, A.H. Mostafid, J. Palou, B.W.G. van Rhijn, S . F. Shariat, R. Sylvester, R. Zigeuner Guidelines Associates: O. Capoun, D. Cohen, J.L. Dominguez-Escrig, B. Peyronnet, T. Seisen, V. Soukup © European Association of Urology 2020 TABLE OF CONTENTS PAGE 1. INTRODUCTION 4 1.1 Aim and objectives 4 1.2 Panel composition 4 1.3 Available publications 4 1.4 Publication history & summary of changes 4 1.4.1 Summary of changes 4 2. METHODS 6 2.1 Data identification 6 2.2 Review 7 3. EPIDEMIOLOGY, AETIOLOGY AND PATHOLOGY 7 3.1 Epidemiology 7 3.2 Risk factors 8 3.3 Histology and classification 9 3.3.1 Histological types 9 3.4 Summary of evidence and recommendations for epidemiology, aetiology and pathology 9 4. STAGING AND CLASSIFICATION SYSTEMS 9 4.1 Classification 9 4.2 Tumour Node Metastasis staging 9 4.3 Tumour grade 9 4.4 Future developments 10 5. DIAGNOSIS 10 5.1 Symptoms 10 5.2 Imaging 10 5.2.1 Computed tomography urography 10 5.2.2 Magnetic resonance urography 10 5.3 Cystoscopy and urinary cytology 11 5.4 Diagnostic ureteroscopy 11 5.5 Distant metastases 11 5.6 Summary of evidence and guidelines for the diagnosis of upper urinary tract urothelial carcinoma (UTUC) 11 6. PROGNOSIS 12 6.1 Prognostic factors 12 6.2 Pre-operative factors 12 6.2.1 Age and gender 12 6.2.2 Ethnicity 12 6.2.3 Tobacco consumption 12 6.2.4 Tumour location, multifocality, size and hydronephrosis 13 6.2.5 Surgical delay 13 6.2.6 Other 13 6.3 Post-operative factors 13 6.3.1 Tumour stage and grade 13 6.3.2 Lymph node involvement 13 6.3.3 Lymphovascular invasion 13 6.3.4 Surgical margins 13 6.3.5 Other pathological factors 13 6.4 Molecular markers 13 6.5 Predictive tools 13 6.5.1 Bladder recurrence 14 6.6 Risk stratification of non-metastatic UTUC 14 6.7 Summary of evidence and guidelines for the prognosis of UTUC 14 2 UPPER URINARY TRACT UROTHELIAL CARCINOMA - UPDATE MARCH 2020 7.
    [Show full text]
  • Primary Urothelial Carcinoma of the Ureter: 11-Year Experience in Taipei Veterans General Hospital
    ORIGINAL ARTICLE Primary Urothelial Carcinoma of the Ureter: 11-Year Experience in Taipei Veterans General Hospital Wen-Jung Chen1, Junne-Yih Kuo1,2*, Kuang-Kuo Chen1,2, Alex Tong-Long Lin1,2, Yen-Hwa Chang1,2, Luke S. Chang3 1Division of Urology, Department of Surgery, Taipei Veterans General Hospital, 2Department of Urology and 3Shu-Tien Urological Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C. Background: Urothelial carcinoma of the upper urinary tract is relatively rare, occurring in 5% of all urothelial tumors. Ureteral urothelial carcinoma is even less common than that of the renal pelvis, accounting for about 25% of all upper urinary tract tumors. The aim of this study was to evaluate the clinical behavior, survival, recurrence and prognostic information of primary ureteral urothelial carcinoma from our 11 years of experience at the Taipei Veterans General Hospital. Methods: We retrospectively reviewed 111 patients with ureteral urothelial carcinoma who had been treated in our hospital between January 1993 and December 2003. Tumor staging was according to the 2002 AJCC TNM classification and stage groupings. Patients with stage 0a and stage 0is were categorized as stage 0a/is, and patients with pathologic T stage pTa and pTis were categorized as pTa/is for statistical analysis. The Kaplan-Meier method was used for survival analysis. Results: There were 69 males and 42 females, with a mean age of 70.5 ± 9.4 years at diagnosis. Of the 111 patients, 5 presented with stage 0a/is, 38 with stage I, 23 with stage II, 21 with stage III, and 24 with stage IV.
    [Show full text]